Want to join the conversation?
Medical diagnostic testing company $DGX said that it has received approval from FDA for emergency use of authorization for the Zika virus test. This test was developed by $DGX's subsidiary Quest's Focus Diagnostics. $DGX added that it plans to make the new test available to physicians for patient testing, including in Puerto Rico, from next week.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.